Our team of dedicated scientists and researchers use their extensive drug development expertise to search for new and existing compounds to incorporate into our technologies to bring new products to market.
Teikoku then develops these products through to regulatory approval (e.g., Lidoderm), or at times we seek licensing or co-development partnerships to advance some of our programs into clinical development and commercialization.
Our history of product successes and a continued dedication to innovation allows us to work with our partners to bring these innovative solutions to market.
These are some of our current partners:
- Eagle Pharmaceuticals
- Endo Pharmaceuticals
- SK Chemicals